Remove the needle & syringe and discard 7
Patients who took injectable semaglutide lost an average of 15%-17% of their body weight in the same amount of time
By targeting glucagon, retatrutide may help the body access and use stored energy more efficiently, while the targeted GLP-1 and GIP hormones help support fullness, appetite control, and blood sugar regulation
Proceeds will primarily advance CX11, an oral small molecule GLP-1 RA, currently in Phase 2 in the United States and Phase 3 in China, with plans to progress into global Phase 2 trials for Type 2 Diabetes Mellitus and initiate Phase 3 development
It includes supporting nutrients like alpha lipoic acid
Another dimension of exploration involves tissue remodeling and structural protein turnover